Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people…
RESEARCH TRIANGLE PARK, N.C., April 26, 2023 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…
Positive opinion paves way for first new treatment option in hidradenitis suppurativa (HS) in nearly…
LOS GATOS, Calif., April 26, 2023 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis”…
Multifamily office taps tru for ability to support existing clients while enabling growth PORTLAND, Ore.–(BUSINESS…
SARASOTA, Fla.–(BUSINESS WIRE)–Helios Technologies, Inc. (NYSE: HLIO) (“Helios” or the “Company”), a global leader in…
OMAHA, Neb.–(BUSINESS WIRE)–Valmont® Industries, Inc., a global leader that provides vital infrastructure and advances agricultural…
MENLO PARK, Calif.–(BUSINESS WIRE)–#ai–Verta, the Operational AI company, today previewed findings from the 2023 AI…
Respondents seeing revenue increases broadly despite possible recession risk PROVIDENCE, R.I.–(BUSINESS WIRE)–#CBCI–Citizens announced today that…
NEW YORK and VIENNA, Austria, April 26, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:…
NEW YORK and VIENNA, Austria, April 26, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:…
Primary analysis of NATALEE, the first and only positive Phase III study of a CDK4/6…
Primary analysis of NATALEE, the first and only positive Phase III study of a CDK4/6…
CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company…
CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company…
SOUTH SAN FRANCISCO, Calif., April 26, 2023 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO),…
SOUTH SAN FRANCISCO, Calif., April 26, 2023 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO),…
Builds on recent preclinical data presented at AACR supporting the use of CCNE1 amplification and…
Builds on recent preclinical data presented at AACR supporting the use of CCNE1 amplification and…
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage…